Axonics Inc. (AXNX): Kapitalisasi marang pendapatan
The revenue multiple for Axonics, Inc. (AXNX) reflects the dynamics of a fabless production model with a California-based engineering center. The level of 2.70 represents the current value of this metric. Price stability is driven by the moderate cyclicality of demand for elective procedures. An impeccable reputation among global surgeons guarantees brand resilience, confirming the long-term business development trajectory shown on this chart.
Rincian analitis perusahaan Axonics Modulation Technologies (AXNX)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Axonics, Inc.|AXNX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Axonics, Inc|AXNX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Axonics Modulation Technologies|AXNX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Axonics|Rasio jangkoan perantara axonics.com
- data bathi lan kelipatan valuasi:
AXNX - Bathi resik|Bathi resik sing dikarepake Axonics, Inc.|AXNX - Rasio rega marang bathi|Pangali forward rega marang bathi Axonics Inc.|AXNX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Axonics Modulation Technologies|AXNX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Axonics|AXNX - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan axonics.com|AXNX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Axonics, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:AXNX axonics.com
Axonics, Inc. generates revenue through the sale of implantable neuromodulation systems for the therapy of urological and proctological dysfunctions. By analyzing the historical P/S, an investor assesses the company's market value relative to its operating revenues, which allows for determining the degree of overpayment for the business and comparing current capitalization with the fundamental ability to generate cash flow over the long term.
Pesaing Axonics, Inc.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|VANI: Multiplikator P/S|Xtant Medical (XTNT) - Multiplikator P/S|Kapitalisasi marang pendapatan NMTC|Rasio kapitalisasi marang pendapatan MODD (Modular Med)|Rasio rega marang pendapatan Myomo, Inc (MYO)|COCH - Rega marang dodolan|Rasio rega marang pendapatan Vivos Therapeutics VVOS|NVNO: Rasio kapitalisasi marang pendapatan|SINTX Technologies - Multiplikator P/S|Koefisien rega marang pendapatan Tenon Medical Inc. TNON|LFWD: Multiplikator P/S|Kapitalisasi marang pendapatan Autonomix Medical|Rasio rega marang pendapatan INVO Fertility Inc|bonebiologics.com (BBLG) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (BIOLASE)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)
